Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2509-2723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age ; volume:44 ; number:6 ; day:19 ; month:10 ; year:2022 ; pages:2925-2931 ; date:12.2022
GeroScience ; 44, Heft 6 (19.10.2022), 2925-2931, 12.2022
- Urheber
-
Cummings, Steven R.
Kritchevsky, Stephen B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11357-022-00671-8
- URN
-
urn:nbn:de:101:1-2023030321010220484117
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cummings, Steven R.
- Kritchevsky, Stephen B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Endpoints for clinical trials in retinal diseases
Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
Methods for planning and analyzing clinical trials with composite endpoints
Imaging endpoints for clinical trials in Alzheimer’s disease
Improving the analysis of composite endpoints in rare disease trials
Endpoints for clinical trials in retinal diseases
Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
Methods for planning and analyzing clinical trials with composite endpoints
Imaging endpoints for clinical trials in Alzheimer’s disease
Improving the analysis of composite endpoints in rare disease trials
Endpoints for clinical trials in retinal diseases
Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
Methods for planning and analyzing clinical trials with composite endpoints
Imaging endpoints for clinical trials in Alzheimer’s disease